Second line chemotherapy in malignant pleural mesothelioma with oxaliplatin/gemcitabine

被引：0
|
作者：
Serke, Monika [1 ]
Xanthopoulos, Anastasios [1 ]
Bauer, Thorsten [1 ]
机构：
[1] Helios Klinikum Emil Behring Berlin, Berlin, Germany
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [41] CHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA - CAMEO
    JETT, JR
    EAGAN, RT
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 82 - 82
  • [42] Chemotherapy in malignant pleural mesothelioma: A review
    Ong, ST
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 1007 - 1017
  • [43] Pemetrexed for malignant pleural mesothelioma: Is it a standard second-line therapy?
    Tamura, Kenji
    Fujiwara, Yasuhiro
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (04) : 248 - 250
  • [44] Irinotecan in combination with gemcitabine as second-line chemotherapy in patients with malignant pleural mesothelioma previously treated with pemetrexed-cisplatin regimen: a phase 2 study
    Fukuoka, Kazuya
    Nakano, Takashi
    Kuribayashi, Kozo
    Iida, Shin-ichiro
    Tamura, Kunihiro
    Tabata, Chiharu
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S771 - S771
  • [45] Comparative effectiveness of second-line immune checkpoint inhibitor therapy versus chemotherapy for malignant pleural mesothelioma
    Kim, Roger Y.
    Li, Yimei
    Marmarelis, Melina E.
    Vachani, Anil
    LUNG CANCER, 2021, 159 : 107 - 110
  • [46] Second-Line Chemotherapy for Malignant Pleural Mesothelioma (MPM): Patterns of Care in Two Australian Tertiary Institutions
    Palmieri, David
    Hui, Rina
    Kao, Steven
    Boyer, Michael
    Park, John
    Nagrial, Adnan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 134 - 134
  • [47] A phase 2 clinical trial of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma (MPM).
    Janne, PA
    Obasaju, C
    Simon, G
    Taub, R
    Kelly, K
    Fidias, P
    Bloss, LP
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 629S - 629S
  • [48] Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma A Single Institution Study
    Tourkantonis, Ioannis
    Makrilia, Nektaria
    Ralli, Maria
    Alamara, Christina
    Nikolaidis, Ilias
    Tsimpoukis, Sotirios
    Charpidou, Andriani
    Kotanidou, Anastasia
    Syrigos, Kostas
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 38 - 42
  • [49] Successful Salvage Chemotherapy with Gemcitabine and Vinorelbine in a Malignant Pleural Mesothelioma Patient Previously Treated with Pemetrexed
    Agatsuma, Toshihiko
    Koizumi, Tomonobu
    Yasuo, Masanori
    Urushihata, Kazuhisa
    Tsushima, Kenji
    Yamamoto, Hiroshi
    Hanaoka, Masayuki
    Fukushima, Mana
    Honda, Takayuki
    Kubo, Keishi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (12) : 1180 - 1183
  • [50] Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
    Fennell, DA
    Steele, JPC
    Shamash, J
    Sheaff, MT
    Evans, MT
    Goonewardene, TI
    Nystrom, ML
    Gower, NH
    Rudd, RM
    LUNG CANCER, 2005, 47 (02) : 277 - 281
12345